Hospital-grade IV treatments are now available at strip mall clinics for anyone willing to pay. Medical professionals warn ...
Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.